Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyanping Capsules (妇炎平胶囊) is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Wannianqing Pharmaceutical (Jiangxi Wannianqing Pharmaceutical). Formulated as an oral capsule, it is primarily indicated for the treatment of various gynecological infections, including vaginitis (such as trichomonal, bacterial, and fungal/monilial vaginitis) and cervicitis. The medication is typically used to address symptoms associated with the TCM syndrome of "damp-heat downward flow," such as abnormal vaginal discharge and pruritus. The formulation leverages the synergistic antimicrobial, antifungal, and anti-inflammatory properties of its herbal constituents, which commonly include extracts from plants such as *Sophora flavescens* (Kushen) and *Phellodendron amurense* (Huangbai). It is an approved and marketed product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuyanping jiaonang.